In this study we have shown how this variant can contribute to increase cancer risk in BRCA1 carriers, by reducing the mRNA OGG1 expression levels, increasing the DNA damage as a consequence of genomic instability generated, and shortening the telomeres in a synergic way with the BRCA1 mutation. This evidence concerns the gene BRCA1 and cancer.